Payment & Shipping Terms:
|CAS:||62613-82-5||Alias:||Oxiracetam, Nootropics, 4-HYDROXY-2-OXOPYRROLIDINE-N-ACETAMIDE|
|Apparence:||Almost White Crystalline Powder||Purity:||99.5%|
|Usage:||Memory Enhancement Noopept||Stock:||Enough Stock|
Nootropics Active Pharmaceutical Ingredients Oxiracetam Brain Improve 62613-82-5
|ALSO KNOWN AS||2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide, 4-Hydroxy-2-oxopyrrolidine-N-acetamide, 4-hydroxy-2-oxo-pyrrolidinoacetamide, ISF 2522, Oxiracetamum, 4-hydroxypiracetam|
|CATEGORY||Nootropic, Racetam, Ampakine|
|TYPE||Nootropic Agent, Central Stimulant, Cognitive Enhancer, Psychotropic Drugs|
Senile Dementia of the Alzheimer’s type
Multi-Infarct and Mixed Dementia
Organic Brain Syndrome
Traumatic Brain Injury
Organic Solvent Exposure
Focus & Concentration
Studying & Academic Performance
Oxiracetam is a racetam nootropic and smart drug used to promote cognitive function. Research shows positive effects for attention span, memory, and mental energy.
Oxiracetam has similar effects to other members of the racetam family, but is 3-5 times more potent than Piracetam, from which it is derived.
It has a long biological half-life of up to 8 hours with a similar onset of effects between 30 – 90 minutes. This nootropic demonstrates a higher rate of oral bioavailability than Piracetam.
HOW IT WORKS
Heightens focus, alertness & perception
Promotes analytical thinking & memory
Boosts energy & reduces mental fatigue
Between 400 - 2,400 mg per day
Oxiracetam has been shown improve symptoms of cognitive dysfunction in the treatment of dementia and other forms of mental impairment.
This racetam nootropic has not been studied as a cognitive enhancer in healthy, young adults. All of the evidence we have of its purported nootropic benefits in this population comes from anecdotal user reviews.
It has been studied in healthy experimental animals and has improved learning and memory. This suggests it may be able to promote brain function in normal humans.
Medical Uses Of Oxiracetam
There has been limited medical use of Oxiracetam compared to other nootropic drugs. It has not been widely prescribed for therapeutic use.
Over 50 different human clinical trials have been conducted to determine the effects of this cognitive enhancer. Many studies have been conducted in Italy where it was first developed and marketed.
Some research suggests that it has the potential to improve cognitive function in individuals with impairments due to aging, multi-infarct dementia and Alzheimer’s disease.
It has also been studied in models of traumatic brain injury and in patients with organic brain syndrome due to prolonged exposure to organic solvents. It is of interest for its potential use in epilepsy, stroke recovery, post-concussion syndrome, motor dysfunction and other neurological problems.